Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000732212 | SCV000860135 | uncertain significance | not provided | 2018-03-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002535259 | SCV003471234 | uncertain significance | Facioscapulohumeral muscular dystrophy 2 | 2022-02-21 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 596391). This variant has not been reported in the literature in individuals affected with SMCHD1-related conditions. This variant is present in population databases (rs577011893, gnomAD 0.01%). This sequence change replaces isoleucine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 608 of the SMCHD1 protein (p.Ile608Met). |
Revvity Omics, |
RCV000732212 | SCV003821945 | uncertain significance | not provided | 2019-09-13 | criteria provided, single submitter | clinical testing |